2024 Avoca Industry Report: ICH E6 (R3) Impact & Preparedness
This year, Avoca's research focuses on potential changes in regulatory guidance under ICH E6 (R3) to gain understanding of current awareness and perceived impacts among clinical trial stakeholders to navigate the path forward.
Access The 2024 Avoca State of the Industry Report:
Anticipating ICH E6 (R3): Awareness, Impact & Preparedness